(Q70381668)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Medical treatment of cholesterol gallstones by bile desaturating agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

author name string

A F Hofmann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

English

0 references

publication date

1 September 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

5 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

199S-208S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

Dissolution of Cholesterol Gallstones by Chenodeoxycholic Acid

10 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Effects of dose relative to body weight in the National Cooperative Gallstone Study: a fixed-dose trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Dissolution of cholesterol gallstones by ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Mesophase formation during in vitro cholesterol gallstone dissolution: a specific effect of ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Sulfation of Lithocholate as a Possible Modifier of Chenodeoxycholic Acid-induced Elevations of Serum Transaminase in Patients with Gallstones

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Ultrastructural Evidence of Intrahepatic Cholestasis Before and After Chenodeoxycholic Acid Therapy in Patients with Cholelithiasis: The National Cooperative Gallstone Study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

A Prospective Morphologic Evaluation of Hepatic Toxicity of Chenodeoxycholic Acid in Patients with Cholelithiasis: The National Cooperative Gallstone Study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Discrepancy between ultrasound and oral cholecystography in the assessment of gallstone dissolution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Low-Dose Chenodiol to Prevent Gallstone Recurrence After Dissolution Therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Cholesterol gallstone dissolution rate accelerators I: Exploratory investigations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040837

7 January 2021

Identifiers

DOI

10.1002/HEP.1840040837

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6384003%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference